Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer (SCLC): GOIRC-AIFA FARM6PMFJM trial.
2016 ◽
Vol 34
(15_suppl)
◽
pp. 8513-8513
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2007 ◽
Vol 2
(8)
◽
pp. S632
◽
Keyword(s):
2008 ◽
Vol 26
(15_suppl)
◽
pp. 3-3
◽
Keyword(s):
2013 ◽
Vol 8
(1)
◽
pp. 23-28
◽
Keyword(s):
2007 ◽
Vol 2
(8)
◽
pp. S340-S341
◽
Keyword(s):
Keyword(s):
Keyword(s):